Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices
暂无分享,去创建一个
M. Dake | M. Jaff | G. Ansel | J. Pompa | Tony Yoder
[1] Jean-Paul Beregi,et al. Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery: Long-Term Results from the SIROCCO Trial , 2006, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[2] Johannes Lammer,et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. , 2006, The New England journal of medicine.
[3] M. Bates,et al. Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: A randomized trial , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[4] Chris J. Hebert,et al. Nitinol Stent Fractures in the SFA The biomechanical forces exerted on the SFA provide a "stiff " challenge to endovascular stenting. , 2004 .
[5] Gerhard Ziemer,et al. Sirolimus-Eluting Stents for the Treatment of Obstructive Superficial Femoral Artery Disease: Six-Month Results , 2002, Circulation.